These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28450161)

  • 1. A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells.
    Chen TC; Yu J; Nouri Nigjeh E; Wang W; Myint PT; Zandi E; Hofman FM; Schönthal AH
    Cancer Lett; 2017 Aug; 400():161-174. PubMed ID: 28450161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting.
    Ganapathy-Kanniappan S; Kunjithapatham R; Geschwind JF
    Anticancer Res; 2013 Jan; 33(1):13-20. PubMed ID: 23267123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes.
    Ehrke E; Arend C; Dringen R
    J Neurosci Res; 2015 Jul; 93(7):1138-46. PubMed ID: 25196479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy.
    Majkowska-Skrobek G; Augustyniak D; Lis P; Bartkowiak A; Gonchar M; Ko YH; Pedersen PL; Goffeau A; Ułaszewski S
    Anticancer Drugs; 2014 Jul; 25(6):673-82. PubMed ID: 24557015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.
    Amorim R; Pinheiro C; Miranda-Gonçalves V; Pereira H; Moyer MP; Preto A; Baltazar F
    Cancer Lett; 2015 Aug; 365(1):68-78. PubMed ID: 26021766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCT1, MCT4 and CD147 expression and 3-bromopyruvate toxicity in colorectal cancer cells are modulated by the extracellular conditions.
    Pereira-Vieira J; Azevedo-Silva J; Preto A; Casal M; Queirós O
    Biol Chem; 2019 May; 400(6):787-799. PubMed ID: 30699066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins.
    Bodur C; Karakas B; Timucin AC; Tezil T; Basaga H
    Mol Carcinog; 2016 Nov; 55(11):1584-1597. PubMed ID: 26373689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.
    Queirós O; Preto A; Pacheco A; Pinheiro C; Azevedo-Silva J; Moreira R; Pedro M; Ko YH; Pedersen PL; Baltazar F; Casal M
    J Bioenerg Biomembr; 2012 Feb; 44(1):141-53. PubMed ID: 22350013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine deprivation enhances antitumor activity of 3-bromopyruvate through the stabilization of monocarboxylate transporter-1.
    Cardaci S; Rizza S; Filomeni G; Bernardini R; Bertocchi F; Mattei M; Paci M; Rotilio G; Ciriolo MR
    Cancer Res; 2012 Sep; 72(17):4526-36. PubMed ID: 22773663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition.
    Vander Linden C; Corbet C; Bastien E; Martherus R; Guilbaud C; Petit L; Wauthier L; Loriot A; De Smet C; Feron O
    Cell Rep; 2021 Jun; 35(9):109202. PubMed ID: 34077729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprive to kill: glutamine closes the gate to anticancer monocarboxylic drugs.
    Cardaci S; Ciriolo MR
    Autophagy; 2012 Dec; 8(12):1830-2. PubMed ID: 22932475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate.
    Nilsson H; Lindgren D; Mandahl Forsberg A; Mulder H; Axelson H; Johansson ME
    Cell Death Dis; 2015 Jan; 6(1):e1585. PubMed ID: 25569102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
    Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X
    Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH.
    Azevedo-Silva J; Queirós O; Ribeiro A; Baltazar F; Young KH; Pedersen PL; Preto A; Casal M
    Biochem J; 2015 Apr; 467(2):247-58. PubMed ID: 25641640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
    Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system.
    Valenti D; Vacca RA; de Bari L
    J Bioenerg Biomembr; 2015 Dec; 47(6):493-506. PubMed ID: 26530987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
    Ganapathy-Kanniappan S; Vali M; Kunjithapatham R; Buijs M; Syed LH; Rao PP; Ota S; Kwak BK; Loffroy R; Geschwind JF
    Curr Pharm Biotechnol; 2010 Aug; 11(5):510-7. PubMed ID: 20420565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent.
    Dell'Antone P
    Med Chem; 2009 Nov; 5(6):491-6. PubMed ID: 19534685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioorthogonal Profiling of a Cancer Cell Proteome Identifies a Large Set of 3-Bromopyruvate Targets beyond Glycolysis.
    Darabedian N; Chen TC; Molina H; Pratt MR; Schönthal AH
    ACS Chem Biol; 2018 Nov; 13(11):3054-3058. PubMed ID: 30395437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor and chemosensitizing action of 3-bromopyruvate: Implication of deregulated metabolism.
    Yadav S; Pandey SK; Kumar A; Kujur PK; Singh RP; Singh SM
    Chem Biol Interact; 2017 May; 270():73-89. PubMed ID: 28433571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.